Physician profile
Kyle A Dunn
NPI 1437728326
$2,885.83
in general payments reported to CMS, 2019-2025
8 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $345 · 2023: $2,138 · 2024: $95.41 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,532 · Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,532.35 |
| Food and Beverage | $1,008.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $1,633.55 | 2023 | Osteomed |
| Depuy Synthes Sales INC. | $745.23 | 2022-2024 | Trumatch, Matrixmandible |
| Kls-Martin L.P. | $246.39 | 2022-2025 | |
| Dentsply Sirona INC | $93.49 | 2023 | Atlantis |
| Axogen | $70.41 | 2024-2025 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Stryker Corporation | $60.66 | 2022-2025 | Na, Vsp System, Vsp Cranial, Smartlock |
| Straumann USA LLC | $24.15 | 2025 | |
| Zimvie INC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.